Ivermectin Treatment Coverage Validation in Two Onchocerciasis Endemic Districts in Ethiopia: A Community-Based Cross-Sectional Study, 2019

Figures & data

Table 1 Ivermectin Offering Disaggregated by Socio-Demographic Characteristic of Study Participants, Ethiopia 2019

Characteristics	Category	Study Population	IVM Offered		X^2	P-value
			Yes N (%)	No N (%)
District	Wombera	1681	1539 (91.4)	142 (8.5)	70.467	P<0.001*
	Itang	2077	1705 (81.9)	372 (17.9)
Gender	Male	1849	1610 (86.8)	239 (12.9)	1.741	P=0.187
	Female	1909	1634 (85.6)	275 (14.4)
Age category (years)	5–14	1124	978 (86.6)	146 (12.9)	0.64	P=0.42
	≥15	2634	2266 (85.9)	368 (14)
SAC attendance	Yes	955	867 (90.6)	88 (9.2)	77.29	P<0.001*
	No	169	111 (64.53)	58 (33.73)

Note: *Variables with P-value<0.05.

Table 2 Treatment Coverage of Ivermectin Against Onchocerciasis in Ethiopia, 2019

Characteristics	Category	Frequency (Study Population)	Treated with IVM	Treatment Coverage (%)
Districts	Wombera	1683	1537	91.3
	Itang special	2082	1698	81.5
	Overall	3765	3235	85.9
Gender	Male	1855	1606	86.6
	Female	1910	1629	85.3
Age category (years)	5–14	1129	973	86.2
	≥15	2636	2262	85.8
School attendance	Yes	957	863	90.2
	No	172	110	64

Table 3 Ivermectin Swallowing Status Among Individuals Who Were Offered Treatment, Disaggregated with Other Variables, Ethiopia, 2019

Characteristics	Category	IVM Offered	Swallowed IVM			X^2	P-value
			Yes (%)	No (%)	Unknown (%)
District	Wombera	1539	1537 (99.9)	1 (0.06)	1 (0.06)	5.031	0.081
	Itang	1705	1698 (99.6)	7 (0.4)	0
Gender	Male	1610	1606 (99.7)	3 (0.2)	1 (0.1)	1.486	0.476
	Female	1634	1629 (99.7)	5 (0.3)	0
Age in years	5–14	978	973 (99.5)	4 (0.4)	1 (0.1)	3.822	0.148
	≥15	2266	2262 (99.8)	4 (0.2)	0
SAC attendance	Yes	867	863 (99.5)	4 (0.5)	0	30.581	0.001
	No	111	110 (99.1)	0	1 (0.9)

Figure 1 Reported reasons of participants for not being offered treatment for onchocerciasis during MDA, 2019 (N=514). (**Others include “did not like drugs”, “not given for adults”, “do not attend schools”, “forgot about the deworming”, “fear of side effects” and “unable to move”).

Figure 2 Comparison between reported and surveyed PC coverage against onchocerciasis in Wombera and Itang special districts in Ethiopia, 2019.